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The  majority  of  tumours  of  the  ureter  (approximately  95%)  are  primitive  epithelial
tumours,  generally  transitional  cell  carcinomas.  Leiomyosarcoma  is  an  extremely  rare
tumour  since  only  about  20  cases  have  ever  been  described  in  the  literature  [1].  We  report
a  case  of  leiomyosarcoma  of  the  ureter  detected  by  CT.
Observation
Mrs  R.,  aged  57,  had  had  abdominal  pain  predominantly  in  the  right  lumbar  fossa  for  sev-
eral  weeks.  Ultrasound  exploration  was  therefore  undertaken  and  revealed  isolated  right
ureterohydronephrosis.  A  double  J  ureteral  endoprosthesis  was  inserted  to  alleviate  the
pain.  Secondly,  a  CT  urogram  was  carried  out  and  revealed  a  well  limited  and  rounded
retroperitoneal  mass  with  peripheral  enhancement  which  was  in  very  close  contact  with
the  right  ureter  (Figs.  1  and  2).  No  other  signiﬁcant  abnormality  came  to  light,  particularly
none  of  the  bladder.  Two  hypotheses  were  put  forward:  either  retroperitoneal  adenomegaly
extrinsically  compressing  the  ureter  or  an  urothelial  tumour  developing  extrinsically.  A
diagnostic  biopsy  was  performed.  From  the  anatomopathological  analysis  and  more  partic-
ularly,  study  of  the  immunohistochemical  markers,  it  was  possible  to  conﬁrm  the  diagnosis
of  leiomyosarcoma  of  the  ureter  (Figs.  3  and  4).  An  additional  PET  scan  conﬁrmed  a
retroperitoneal  right  para-ureteral  focus  of  hyperﬁxation,  with  no  other  focus  of  hyperﬁx-
ation  in  the  lymph  nodes  (Fig.  5).  Complete  surgical  exeresis  of  the  lesion  was  undertaken
with  confection  of  a  termino-terminal  ureteroureteral  anastomosis.  Postoperative  monitor-
ing  was  simple.  Since  the  patient’s  general  condition  permitted  it,  adjuvant  chemotherapy
was  started.  Early  scan  checks  and  at  9  months  did  not  reveal  any  signs  of  complication,
nor  of  recurrence.
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Figure 1. Abdominopelvic computed tomography on portal phase in axial section showing a right retroperitoneal mass syndrome [upper
pole of the lesion (a) and middle portion (b)] in very close contact with the ureter identiﬁed by the J stent (arrow).
Figure 2. Abdominopelvic computed tomography on portal phase in coronal MIP reconstructions (a) and sagittal (b) focus on the right
 with ureter in its proximal portion. Limited and rounded peritoneal mass
light is detected by the J stent (arrow).Discussion
Ureteral  leiomyosarcoma  is  an  extremely  rare  malignant
mesenchymal  tumour,  since  only  some  20  cases  have  been
Figure 3. Histology, magniﬁcation 250, HE staining: dense prolif-
eration of fasciculated spindle cells.
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aa peripheral enhancement, in close contact with the ureter, whoseescribed  in  the  literature  [1].  The  circumstances  in  which
t  is  mainly  detected  involve  lumbar  pain  associated  with
acroscopic  haematuria  [2].  Its  prognosis  is  poor.  The  sur-
ival  rate  at  5  years  is  in  the  order  of  50%  [2—4]. The  frequent
igure 4. Immunohistochemistry, magniﬁcation 100, anti-actin
ntibody: diffuse and intense cytoplasmic staining of tumor cells.
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figure 5. FDG-PET scan (a, b) revealing a focus of intense upta
ax = 10.5). Otherwise there is no ﬁxation anomaly on the remainin
synchronous  and  metasynchronous)  secondary  localisations
re  reported  (mesentery,  lung,  liver  and  lymphatic  vessels)
2].  Current  treatment  relies  on  complete  surgical  exeresis.
djuvant  management  is  still  highly  debated  but  is  based  on
hemotherapy  (particularly  for  metastatic  disease)  and/or
adiotherapy  (for  a  voluminous  lesion,  and/or  if  the  margins
f  the  exeresis  are  affected)  [1,3].
The  imaging  appearance  of  cross-sections  of  the
eiomyosarcoma  of  the  ureter  has  been  very  little  reported
n  the  literature  owing  to  the  small  number  of  cases  studied,
nd  did  not  seem  speciﬁc.  In  general  the  inﬁltrating  lesion
rose  from  the  wall  of  the  ureter  and  was  seen  as  eccen-
ric  or  circumferential  parietal  thickening  with  no  speciﬁc
nhancement  characteristic  [5].  Our  case  however  was  more
f  a  nodular  mass  of  the  wall  of  the  ureter  developing  exo-
hytically  with  ‘‘crown’’  enhancement  (a  hypodense  centre
nd  highly  enhanced  periphery).  This  type  of  enhance-
ent  is  classically  described  in  malignant  retroperitoneal
umours,  the  hypodensity  of  the  centre  of  the  lesion  wit-
essing  to  necrotic  modiﬁcation  which  is  all  the  more  visible
he  more  voluminous  the  tumours  and/or  the  greater  the
egree  of  malignancy  [6].  The  kinetics  of  enhancement  of
eiomyosarcomas  of  the  ureter  are  not  speciﬁcally  described
n  the  literature,  but  it  would  seem  that  they  are  gener-
lly  enhanced  rather  early  and  massively  with  a  hypodense
ecrotic  centre  showing  their  aggressiveness  [6].  Our  tumour
xhibited  this  type  of  enhancement.
However,  faced  with  a  retroperitoneal  nodular  mass  in
ontact  with  the  ureter  with  a  CT  scan  appearance  as  unspe-
iﬁc  as  described  above,  it  is  necessary  to  put  forward
everal  diagnostic  hypotheses.
Because  of  its  frequency,  we  shall  discuss  urothelial  car-
inoma,  all  the  more  so  since  episodes  have  been  reported
f  haematuria  [7].  This  carcinoma  presents  in  most  cases
s  circumferential  parietal  thickening,  which  is  most  often
ymmetrical,  rapidly  stenosing  and  in  two  thirds  of  the  cases
nvolves  the  distal  ureter  [7,8]. The  lesions  are  therefore
[
t
sorresponding to a cava syndrome displacing the right ureter (SUV
roperitoneal or pelvic lymph nodes.
eadily  multifocal  with  associated  synchronous  involvement
f  the  bladder  in  about  40%  of  cases  [5,7].
The  main  differential  diagnosis  is  extrinsic  compression
f  the  ureter  by  a  tissue  process  and  particularly  by  a
etroperitoneal  adenomegaly.
This  compression  may,  in  order  of  frequency,  be  related
ither  to  lymphoproliferative  proliferation,  to  secondary
ocalisation  of  a  urogenital  cancer,  or  to  an  infection  (tuber-
ulosis).  In  the  ﬁrst  case,  there  are  generally  multiple,
erivascular,  polycyclic  and  conﬂuent  adenomegalies  form-
ng  a  uniform  mass  of  tissue  not  modiﬁed  by  injection.  As  for
etastatic  adenopathies,  the  imaging  appearance  closely
esembles  the  appearance  of  lymphomas,  so  that  the  clinical
ontext  will  suggest  the  diagnosis  more  than  the  anatomical
istribution  of  the  lymph  nodes.  However,  the  tuberculosis
ymph  nodes  above  all  could  have  mimicked  the  appear-
nce  of  our  lesion  since  the  adenopathies  in  question  are
uch  smaller  than  lymphomas,  poorly  conﬂuent  and  showing
ecrotic  hypodensity  in  the  centre  of  the  lesion  with  periph-
ral  enhancement  [6].  Analysing  the  contact  angles  could  in
heory  differentiate  a  lesion  extrinsic  to  the  ureter  of  a  com-
ressive  adenomegaly  type,  which  would  have  acute  contact
ngles,  from  an  intrinsic  lesion,  starting  in  the  wall  of  the
reter  and  developing  exophytically,  like  the  leiomyosar-
oma  in  question,  which  should  have  obtuse  contact  angles.
his  however  is  still  just  theoretical  and  in  practice  it  is
ften  difﬁcult  to  differentiate  these  two  entities.
Other  less  common  metastases  to  be  mentioned  found  in
he  retroperitoneum  originate  mainly  from  melanoma  and
ung  cancer  (extra-adrenal  metastasis)  [6].
Retroperitoneal  ﬁbrosis  presents  as  an  inﬁltration
‘sheathing’’  the  ureter,  usually  medially,  and  is  responsible
or  proximal,  unilateral  or  bilateral  ureterohydronephrosis
6,7].  The  clinical  context  is  again  a  key  element  for  deciding
he  diagnosis.
Faced  with  this  abundance  of  diagnostic  hypothe-
es,  the  diagnosis  is  most  often  conﬁrmed  from  the
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anatomopathological  analysis  of  the  lesion  following  percu-
taneous  or  surgical  biopsy.  In  the  case  of  leiomyosarcoma  of
the  ureter,  the  conﬁrmation  of  the  diagnosis  is  based  more
particularly  on  analysis  of  the  immunohistochemical  mark-
ers.  Indeed,  this  type  of  tumour  has  immunoreactivity  for
smooth  muscle  actin  and  for  h-caldesmon,  which  differenti-
ates  it  from  a  rhabdomyosarcoma  (the  markers  of  which  are
desmin,  myoglobin  and  myogenin)  [1,9,10].
Conclusion
Leiomyosarcoma  of  the  ureter  is  a  rare  tumour  with  a  poor
prognosis,  the  CT  imaging  appearance  of  which  is  little
reported  in  the  literature.  It  is  an  eccentric,  nodular  or
inﬁltrating  lesion  with  no  associated  involvement  of  the
bladder.  The  characteristics  of  enhancement  are  not  sufﬁ-
ciently  speciﬁc  to  make  a  diagnosis.  This  must  therefore  be
based  on  the  anatomopathological  analysis  with  immunohis-
tochemical  markers.  Treatment  is  by  surgery  with  adjuvant
management  which  is  still  to  date  controversial.Disclosure of interest
The  authors  declare  that  they  have  no  conﬂicts  of  interest
concerning  this  article.
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